The procedure of determining the DNA sequence at a specific position within a gene is known as genotyping. Within the same species, DNA sequences differ from species to species and from person to person. Single nucleotide polymorphisms (SNPs), insertion and deletion (indels), and varying gene copy numbers all-cause gene variations. Individual phenotypic qualities are determined by genetic variations. By comparing a DNA sequence to that of another sample or a reference sequence, a genotyping assay can reveal genetic differences. Population genomics, disease association, agricultural traits, and microbes all benefit from genotyping assays. Polymerase chain reaction (PCR), electrophoresis, microarray, and MALDI-TOF can all be used in a genotyping assay.
MARKET SCOPE
The "Global Genotyping Assay Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the genotyping assay market with detailed market segmentation by product and services, technology, application, and end user. The report provides key statistics on the market status of the leading genotyping assay market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product and service the market is segmented as, reagent and kits, instruments and bioinformatics.
- Based on technology the market is segmented as, PCR, microarrays, NSG, capillary electrophoresis, matrix-assisted laser, desorption/ ionization-time of flight mass spectroscopy, and other technologies.
- Based on application the market is segmented as, Pharmacogenomics, Diagnostics & Personalized Medicine, Animal Genetics, Agricultural Biotechnology, Others.
- Based on end-user the market is segmented as, Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, Other end users.
MARKET DYNAMICS
Drivers:
- Increasing prevalence of genetic diseases and rising awareness on personalized medicine.
- Technological advancements and decreasing prices of dna sequencing is also expected to fuel market growth.
- Growing importance of genotyping in drug development is expected to support market growth.
Restraints:
- Whereas, the high cost of equipment used in genotyping is expected to hamper market growth during the forecast period.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South and Central America. The genotyping assay market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the genotyping assay market in these regions.
IMPACT OF COVID-19 ON GENOTYPING ASSAY MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the genotyping assay market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnerships & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from the genotyping assay market are anticipated to have lucrative growth opportunities in the future with the rising demand for genotyping assay in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the genotyping assay market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd
- QIAGEN
- Danaher
- Agilent Technologies, Inc.
- Fluidigm Corporation
- General Electric Company
- Genewiz, Inc.
- Bio-Rad Laboratories, Inc.